Breast Cancer Research and Treatment

, Volume 29, Issue 1, pp 97–107 | Cite as

Determination of epidermal growth factor receptor provides additional prognostic information to measuring tumor angiogenesis in breast carcinoma patients

  • Noel Weidner
  • Giampietro Gasparini
Guest editor's introduction


Recent studies have shown that women with invasive breast carcinoma having high microvessel density (MVD) (a measure of tumor angiogenesis) or epidermal growth factor receptor (EGFR) expression have increased risk for metastasis and/or decreased survival. To determine if MVD and EGFR expression provide additive prognostic information, we analyzed these two prognostic indicators in the primary invasive breast carcinomas from 165 consecutive patients, who were followed for a median of 51 months. Univariate analysis showed a highly significant (p<0.001) association of MVD with overall and relapse-free survival in all patients, including both node-negative and node-positive groups (see JNCI 84:1875–1887, 1992). For EGFR, although univariate analysis suggested that women with tumors showing EGFR expression relapsed earlier and, perhaps, died earlier, the differences were not statistically significant. Multivariate analysis, in contrast, revealed that determination of EGFR did provide significant additional information to that already provided by MVD for predicting relapse-free survival in all women (p=0.001) and in the subset of node-positive women (p=0.007). Among node-negative women, however, the contribution of EGFR expression in predicting relapse-free survival was not significant (p=0.12). Likewise, EGFR measurement did not provide significant additional information beyond that of MVD alone for predicting overall survival. Thus, EGFR provides additional prognostic information to determination of MVD, but only for relapse-free survival in node-positive women with invasive breast carcinoma.

Key words

breast carcinoma angiogenesis metastasis survival epidermal growth factor receptor blood vessels prognostic factors 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Folkman J: What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst 82:4–6, 1990Google Scholar
  2. 2.
    Blood CH, Zetter BR: Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1032:89–118, 1990Google Scholar
  3. 3.
    Weidner N: The relationship of tumor angiogenesis and metastasis with emphasis on invasive breast carcinoma.In: Weinstein RL (ed) Advances in Pathology and Laboratory Medicine, Vol 5. Mosby Year Book, Chicago IL, 1992, pp 101–122Google Scholar
  4. 4.
    Sainsbury JRC, Farndon JR, Sherbet GV, Harris AL: Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet i:1398–1402, 1987Google Scholar
  5. 5.
    Lewis S, Locker A, Todd JH, et al: Expression of epidermal growth factor receptor in breast carcinoma. J Clin Pathol 143:385–389, 1990Google Scholar
  6. 6.
    Gasparini G, Bevilacqua P, Pozza F, et al: Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer. Brit J Cancer 66:970–976, 1992Google Scholar
  7. 7.
    Weidner N, Semple JP, Welch WR, et al: Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 324:1–8, 1991Google Scholar
  8. 8.
    Bosari S, Lee AKC, DeLellis RA, et al: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23:755–761, 1992Google Scholar
  9. 9.
    Horak E, Leek R, Klenk N, et al: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastasis and survival in breast cancer. Lancet 340:1120–1124, 1992Google Scholar
  10. 10.
    Kaldjian E, Jin L, Lloyd R: Immunohistochemical analysis of breast carcinomas: correlation of estrogen and progesterone receptors, proliferative activity, tumor vascularity, and lymph node metastasis. Mod Pathol 5:14a, 1992Google Scholar
  11. 11.
    Sneige N, Singletary E, Sahin A, et al: Multiparameter analysis of potential prognostic factors in node negative breast cancer patients. Mod Pathol 5:18a, 1992Google Scholar
  12. 12.
    Sahin AA, Sneige N, Ordonez GN, et al: Tumor angiogenesis detected byUlex europaeus agglutinin 1 lectin and factor VIII immunostaining in node-negative breast carcinoma treated by mastectomy: prediction of tumor recurrence. Mod Pathol 6:19a, 1993Google Scholar
  13. 13.
    Visscher DW, Smilanetz S, Drozdowicz S, et al: Prognostic significance of angiogenic capacity in breast carcinoma: an image morphometric study. Mod Pathol 6:21a, 1993Google Scholar
  14. 14.
    Macchiarini P, Fontaini G, Hardin MJ, et al: Relation of neovasculature to metastasis of non-small-cell lung cancer. Lancet 340:145–146, 1992Google Scholar
  15. 15.
    Weidner N, Carroll PR, Flax J, et al: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401–409, 1993Google Scholar
  16. 16.
    Bigler SA, Brawer MK, Deering RE: Neovascularization in carcinoma of the prostate: a quantitative morphometric study. Mod Pathol 5:50a, 1992Google Scholar
  17. 17.
    Wakui S, Furusato M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, Asano K, Tokuda T, Aizawa S, Ushigome S: Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 168:257–262, 1992Google Scholar
  18. 18.
    Bigler SA, Brawer MK, Deering RE, et al: Vessel density in carcinoma of the prostate: comparing organ confined tumors with stage D tumors. Mod Pathol 6:56a, 1993Google Scholar
  19. 19.
    Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84:1875–1887, 1992Google Scholar
  20. 20.
    Office of Medical Applications of Research, National Institutes of Health: Consensus Conference — Adjuvant chemotherapy of breast cancer. J Am Med Assoc 254:3461–3463, 1985Google Scholar
  21. 21.
    Fisher ER, Gregorio RM, Fisher B: The pathology of invasive breast cancer: A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol No. 4). Cancer 36:1–85, 1975Google Scholar
  22. 22.
    Gasparini G, Bevilacqua P, Dal Fior S, et al: Characterization of node-negative breast cancer by clinico-pathologic and biologic factors. Anticancer Res 10:205–208, 1990Google Scholar
  23. 23.
    Bevilacqua P, Gasparini G, Dal Fior S, et al: Immunocytochemical determination of epidermal growth factor receptor with monoclonal EGFR1 antibody in primary breast cancer patients. Oncology 47:313–317, 1990Google Scholar
  24. 24.
    Waterfield MD, Mayers ELV, Stroobant P, et al: A monoclonal antibody to the human epidermal growth factor receptor. J Cell Biochem 20:149–160, 1982Google Scholar
  25. 25.
    Hsu SM, Raine L, Fanger H: A comparative study of the peroxidase antiperoxidase method and an avidinbiotin-complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 75:734–738, 1981Google Scholar
  26. 26.
    Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481, 1958Google Scholar
  27. 27.
    Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163–170, 1966Google Scholar
  28. 28.
    Cox DR: Regression models and life tables (with discussion). J Roy Stat Soc [B] 34:187–220, 1972Google Scholar
  29. 29.
    Cox DR: Analysis of Binary Data. Methuen, London, 1970Google Scholar
  30. 30.
    Ludwig Breast Cancer Study Group: Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 320:491–496, 1989Google Scholar

Copyright information

© Kluwer Academic Publishers 1994

Authors and Affiliations

  • Noel Weidner
    • 1
  • Giampietro Gasparini
    • 2
  1. 1.Department of PathologyUniversity of California at San FranciscoSan FranciscoUSA
  2. 2.St. Bortolo Regional HospitalVicenza-VenetoItaly

Personalised recommendations